RS21304A - Bile acids and derivates thereof as blood-brain barrier permeability modifiers for drugs and poisons - Google Patents

Bile acids and derivates thereof as blood-brain barrier permeability modifiers for drugs and poisons

Info

Publication number
RS21304A
RS21304A YUP-213/04A YUP21304A RS21304A RS 21304 A RS21304 A RS 21304A YU P21304 A YUP21304 A YU P21304A RS 21304 A RS21304 A RS 21304A
Authority
RS
Serbia
Prior art keywords
blood
brain barrier
poisons
drugs
derivates
Prior art date
Application number
YUP-213/04A
Other languages
Serbian (sr)
Inventor
Momir Mikov
Vida Jakovljević
Ksenija Kuhajda
Slavko Kevrešan
Velibor Vasojević
Original Assignee
Momir Mikov
Vida Jakovljević
Ksenija Kuhajda
Slavko Kevrešan
Vasović, Velibor,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momir Mikov, Vida Jakovljević, Ksenija Kuhajda, Slavko Kevrešan, Vasović, Velibor, filed Critical Momir Mikov
Priority to YUP-213/04A priority Critical patent/RS21304A/en
Publication of RS21304A publication Critical patent/RS21304A/en

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

Invention solves the problem of modification of permeability for drugs and poisons through blood-brain barrier through the original procedure for application of bile acids and derivates thereof as blood-brain barrier permeability modifiers.It is unknown that bile acids and derivates thereof administered prior or at the same time with drugs and poisons, modify the passage to drugs and poisons through the blood-brain barrier. Subject matter of the invention consists in, that during application of the solution of bile acid salts and derivates thereof, as well, through the blood-brain barrier. In our work, due to modification of passage of drugs and poisons through blood-brain barrier synthesized are various derivates of natural bile acids.
YUP-213/04A 2004-03-10 2004-03-10 Bile acids and derivates thereof as blood-brain barrier permeability modifiers for drugs and poisons RS21304A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YUP-213/04A RS21304A (en) 2004-03-10 2004-03-10 Bile acids and derivates thereof as blood-brain barrier permeability modifiers for drugs and poisons

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YUP-213/04A RS21304A (en) 2004-03-10 2004-03-10 Bile acids and derivates thereof as blood-brain barrier permeability modifiers for drugs and poisons

Publications (1)

Publication Number Publication Date
RS21304A true RS21304A (en) 2007-02-05

Family

ID=43645922

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-213/04A RS21304A (en) 2004-03-10 2004-03-10 Bile acids and derivates thereof as blood-brain barrier permeability modifiers for drugs and poisons

Country Status (1)

Country Link
RS (1) RS21304A (en)

Similar Documents

Publication Publication Date Title
ATE470443T1 (en) INDOL-1-YL ACID DERIVATIVES
CY1112831T1 (en) AZABIRENYLAMINBENZOIC ACID DERIVATIVES AS DHODH SUPPLY AGENTS
EA200700096A1 (en) DERIVATIVES 2-CARBAMID-4-PHENYL THIAZOLE, METHOD FOR THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY
MY143795A (en) Tetrahydropyridoindole derivatives
WO2007016352A3 (en) Oral liquid losartan compositions
WO2007149406A8 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
WO2005110994A8 (en) Substituted pyrazolyl urea derivatives useful in the treatment of cancer
CY1109722T1 (en) INTERMEDIATE COMPOUNDS FOR PREPARATION OF TRANS-5-CHLORO-2-METHYL-2,3,3A, 12B-TETRAHYDRO-1H-DIBENZ [2,3: 6,73OXEPINO [4,5-C] PYRROLE
EA200601288A1 (en) 1,3-DIPHENYLPROP-2-EN-1-SHE DERIVATIVES, METHOD OF THEIR RECEIVING AND APPLICATION
NO20083287L (en) Drugs for the treatment of tumors, and their use
NO20065271L (en) Compositions including alpha-2-delta ligands
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
TW200727903A (en) Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate
WO2006078384A3 (en) Stilbene derivatives and their use
TW200602076A (en) O, O'-amidomalonate and N, O-amidomalonate platinum complexes
ECSP088745A (en) SUBSTITUTED DERIVATIVES OF CHROMANOL AND ITS USE
CY1115961T1 (en) ORVEPITANT MALEATE ANHYDRATED FORM OF CRYSTAL MALINE
CY1109537T1 (en) Peptides and Peptide Derivatives, PREPARATION OF THESE ALSO USE THESE FOR THE PREPARATION OF THERAPEUTIC AND / OR PREVENTIVE ACTIVE ACTION
NO20076405L (en) Use of 24-nor-UDCA
CL2007000789A1 (en) Malonamide derived compounds, gamma-secretase inhibitors; Preparation process; pharmaceutical composition; and its use in the treatment of Alzheimer's disease.
WO2008010008A3 (en) Cardiovascular combinations using rennin-angiotensin inhibitors
WO2008059041A3 (en) Complementation of factor xi deficiency by factor v mutants
EA200501301A1 (en) MENTHOL SOLUTIONS OF MEDICINES
WO2008050133A3 (en) Inhibition of beta-amyloid aggregation
IS2849B (en) Use of irbesartan in the manufacture of drugs used to prevent or treat pulmonary hypertension